Compare Cigna Corp (CI) vs Royal Caribbean Cruises Ltd (RCL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Royal Caribbean Cruises Ltd — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while Royal Caribbean Cruises Ltd trades at $307 (market cap $82.38B). The key difference: Cigna Corp and Royal Caribbean Cruises Ltd are close in size by market cap, and Cigna Corp pays the higher dividend (2.24%). Which is the better fit depends on your goals.
| CI | RCL | |
|---|---|---|
Market Cap | $73.56B | $82.38B |
Sector | Health | Consumer Cyclical |
52-Week High | $311.00 | $365.84 |
52-Week Low | $244.41 | $246.71 |
Enterprise Value | $98.27B | $105.02B |
Dividend Yield | 2.24% | 1.62% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
Royal Caribbean Group (RCL) trades at $320, down 0.17% on the day, with a bullish technical signal and strong fundamental momentum. The stock is supported by robust earnings beats, with Q2 2026 EPS of $4.21 exceeding the $3.98 estimate, and a consensus analyst price target of $343.09 implying upside. Recent news highlights strong demand, fleet expansion, and a $1.25 billion senior notes offering to fund growth, while cash flow trends show improving operational strength.
The outlook for RCL remains positive, driven by record bookings, pricing power, and strategic investments, though risks include geopolitical impacts on European itineraries, high debt levels, and premium valuations. Investors should weigh the company's solid execution against macroeconomic and industry-specific headwinds for balanced exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Royal Caribbean Cruises Ltd
Royal Caribbean is the world's second-largest cruise company, operating 64 ships across five global and partner brands in the cruise vacation industry, with 10 more ships on order. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises, allowing it to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in the first quarter of 2021.
Read more on RCL →
